II. Epidemiology
- Civilian Radiation Exposure is rare
- Radioation Exposures are typically limited to industrial accidents, terrorist attacks and war zones
III. Definitions
- Radiation
- Energy transmitted from a source through space or objects
- Ionizing Radiation
- Electromagnetic waves or subatomic particles with energy levels capable of removing electrons from atoms
- Examples include higher energy forms of UV light, gamma rays and xrays
- Nuclear materials emit ionizing radiation
- Non-ionizing Radiation
- Lower energy sources that do not cause ionization of atoms (loss of electrons)
- Examples include visible light, laser, infrared light, microwaves, radio waves and low level UV light
- Acute Radiation Syndrome
- Radiation Exposure resulting in severe, specific organ injury with risk of death within hours to months
- Radiation-Induced Multiorgan Failure
- Progressive dysfunction of 2 or more organ systems over time as a result of ionizing Radiation Exposure
- Radiation Combined Injury
- Radiation Injury AND blunt Trauma, Penetrating Trauma, Burn Injury, Blast Injury or infection
IV. Pathophysiology
- Body tissues with high cell turnover (high mitotic index) are most susceptible to ionizing radiation
- Radiation particle type dictates the cell targets and degree of injury
- Alpha Particles (e.g. Radon Gas)
- Composed of 2 protons and 2 neutrons, with low penetration (blocked by clothing)
- Injury is by inhalation with alveolar injury or ingestion with intestinal mucosa injury
- Associated with secondary cancer development
- Beta Particles (e.g. nuclear power plants, medical nulcear material)
- Composed of electrons, with higher penetration than alpha particles (but will not penetrate clothing)
- Risk of Skin Injury, ingestion and Inhalation Injury
- Gamma Rays (e.g. nuclear explosion)
- Mass-Less, high energy electromagnetic radiation rays with high penetration
- Alpha Particles (e.g. Radon Gas)
- Radioactive material exposure types
- As of 2025, no U.S. clinician has been harmed caring for patients with radiation contamination or exposure
- Direct exposure (e.g. nuclear explosion)
- Close proximity to radiation source
- Patient's removed from radiation source do not expose others (i.e. emit radiation)
- Contamination (e.g. ingestion of contaminated food or water)
- Patient contains radioactive material on their skin and clothing (e.g. dust), or inhaled or ingested
- Contaminated patients can still emit radiation and expose other before Decontamination
- Initiate Decontamination procedures
- Sources
- External Radiation Exposure (most common)
- Source is outside the human body (no continued exposure after removal from external source)
- See risk factors below
- Internal Radiation Exposure (rare)
- Patient is exposed via radiation ingestion, inhalation, injection or absorption
- Patient remains contaminated with continued Radiation Exposure to themselves and others
- External Radiation Exposure (most common)
- Radiation Exposure levels correlate with effects and mortality
- Dose reflects whole body or significant partial body Radiation Exposure
- Gray (Gy) is the the preferred, SI measurement unit of absorbed radiation
- Rad is the radiation measurement unit used in the United States
- One Gray is equivalent to 100 rads
- Dose >1 Gy
- Threshold for Acute Radiation Syndrome
- Dose >2 to 3 Gy
- Hematopoietic Syndrome
- Dose 3.5 to 4 Gy
- Lethal Dose in 50% of patients within 60 days (LD50/60) without supportive care
- With general supportive care LD50/60 increases to 4.5 to 7 Gy
- With rapid Intensive Care, reverse isolation, Bone Marrow TransplantLD50/60 increases to 7 to 9 Gy
- Radiation Exposures >=10 Gy are nearly 100% lethal regardless of treatment
- Dose >5 to 12 Gy
- Gastrointestinal Syndrome
- Dose >10 to 12 Gy
- Uniformly lethal dose
- Dose >10 to 20 Gy
- Cerebrovascular Syndrome
- Dose reflects whole body or significant partial body Radiation Exposure
V. Risk Factors
- High risk exposures
- Nuclear power reactor exposure
- Industrial or research facility exposure
- Nuclear weapons
- Overexposure
- Medical exposures were responsible for 60% of all radiation accidents and overexposures, 1980-2013
- Medical intervention providers
- Interventional cardiology
- Interventional Radiology
- Sealed source radiation (higher radiation activity if accidental release)
- Unsealed source radiation (lower radiation activity)
- Stress Imaging using thalium-201
- Radio-Iodine-131 for Thyroid ablation)
- Other exposures
- Radioactive material transport
- Radioactive waste management
VI. HIstory
- Location of exposure in relation to radiation source
- Injuries related to exposure (including burn injuries)
- Dose of exposure
- High dose rate (high dose over short period) is associated with increased injury
- Dose rate decreases by the square of the distance from the source
- Shielding reduces exposure
VII. Findings: Acute Radiation Syndrome
- Prodromal Phase (0 to 2 days after exposure)
- Symptoms reflect severity of exposure
- Lower dose exposures (<1 Gy) may be associated with mild or absent symptoms
- Significant, potentially lethal exposures (>2 Gy) are associated wih symptoms in the first 2 hours
- Highly lethal doses (>10 to 20 Gy) are associated with symptom onset within minutes of exposure
- Anorexia
- Nausea
- Vomiting
- Diarrhea
- Fever
- Tachycardia
- Headache
- Apathy
- Symptoms reflect severity of exposure
- Latent Phase (2 to 20 days after exposure)
- Symptoms temporarily abate during latent phase
- In high Radiation Exposures, latent phase may only last hours
- Manifest Illness (21 to 60 days after exposure)
- Severe, often life-threatening effects of organ dysfunction
- Findings specific to the associated hematopoietic, GI and CNS syndromes (see below)
- Recovery Phase
- Radiation Exposure 2 to 6 Gy
- Recovery over weeks to months
- Radiation Exposure 6 to 8 Gy
- Recovery over months to years
- Radiation Exposure 2 to 6 Gy
VIII. Findings: Associated Syndromes
- Cutaneous Syndrome
- See Burn Injury
- Considered separately from the primary Radiation Syndromes (hematopoietic, GI and CNS)
- Cutaneous Radiation Injury (isolated without other syndrome involvement)
- Cutaneous Radiation Syndrome (combined with hematopoietic, GI or CNS syndromes)
- Prodromal findings (within 1-2 days)
- Skin erythema and edema (capillary dilation)
- Bullae
- Latent Phase
- Duration 1 to 5 weeks (shorter in high dose cutaneous exposures)
- Manifest Illness
- Cutaneous Radiation Injury (<2 Gy)
- Full effects may be delayed years
- Cutaneous Radiation Syndrome (higher skin exposures >20-40 Gy)
- Desquamation (dry or moist)
- Skin Ulceration (may affect deep tissue down to Muscle or bone)
- Onycholysis
- Cutaneous Radiation Injury (<2 Gy)
- Hematopoietic Syndrome (Dose >0.7 Gy, and esp. >2 to 3 Gy)
- Prodromal Findings
- Lymphopenia (see labs above)
- Earliest affected cell line after Radiation Exposure
- See labs below
- Neutropenia and Thrombocytopenia nadir at 2 to 4 weeks, but may persist months
- Anemia (also compounded by gastrointestinal Hemorrhage)
- Lymphopenia (see labs above)
- Latent Phase
- Typically asymptomatic, while Bone Marrow cells die
- Manifest Findings (over weeks to months)
- Bone Marrow aplasia or hypoplasia
- Pancytopenia
- Immunocompromised
- Poor Wound Healing
- Increased bleeding risk
- Prodromal Findings
- Gastrointestinal Syndrome (Dose >5 to 12 Gy)
- Onset within 5 days of exposure
- Mild GI symptoms (Nausea, Vomiting) are seen at low dose exposures (<1.5 Gy) in prodromal phase
- High dose exposures (>5 Gy) are associated with loss of intestinal crypt cells and mucosal barrier
- Associated with more severe Abdominal Pain and Diarrhea, with subsequent Gastrointestinal Bleeding
- Management includes fluid and Electrolyte replacement, and in some cases Total Parenteral Nutrition
- Prodromal Findings
- Manifest Findings (typically after day 7)
- Cerebrovascular Syndrome (Dose >10 to 20 Gy)
- Associated with capillary injury at blood brain barrier, Cerebral edema and Meningitis
- Onset within minutes to hours of exposure, and minimal prodromal and latent phases
- Most patients die within 3 days of symptom onset (survival is rare)
- Manifest Findings
- Severe Nausea and Vomiting
- Headache
- Altered Mental Status
- Seizures
- Ataxia
- Decreased Deep Tendon Reflexes
- Generalized intracranial edema (on CT or MRI)
IX. Labs
- See Unknown Ingestion
- Mouth and nasal swabs for radiation testing
- ABO Type and Screen
- Obtain specific HLA testing before transfusion of any blood or Platelets
-
Complete Blood Count (CBC) with differential
- Repeat CBC every 6 to 12 hours for first 3 days
- Observe for decreased White Blood Cells (esp. Absolute Lymphocyte Count)
- Absolute Lymphocyte Count depletion course best predicts exposure and prognosis
- Lymphocyte Count decreases first after Radiation Exposure
- Absolute Lymphocyte Count >50% of normal at 48 hours after exposure is reassuring
- Associated with >90% survival
- Predicts Radiation Exposure <1 Gy
- Lymphocyte Count >1000 is associated with a better prognosis
- Lymphocyte Count maintained at 50% of normal in first week suggests <1 Gy exposure
- Lymphocyte Count <500 is associated with very poor prognosis (highly lethal if <100)
- High dose exposure (>5 Gy): 50% Lymphocyte drop in 24 hours, and more severe drop in 48 hours
- Absolute Lymphocyte Count depletion course best predicts exposure and prognosis
- Other daily labs for first 3 days
- Serum Electrolytes
- C-Reactive Protein
- Serum Amylase
- Marker of parotid gland Radiation Exposure
X. Management: Hospital Arrival and Decontamination
-
General
- See Mass Casualty Incident
- Consult radiation and nuclear exposure experts
- Staff should use appropriate Personal Protective Equipment (PPE)
- No special radiation suit exists
- Masks (N95 Mask, PAPR or CAPR)
- Droplet precautions (gowns or jumpsuits and gloves)
- Water-resistant clothing
- Caps
- Shoe covers
- Protective eye wear
- Double glove
- Inner glove set (closest to skin) is taped to clothing
- Outer glove set is changed frequently
- Personal Radiation dosimeter (if available)
- Worn under protective clothing
-
Decontamination
- Life saving interventions (e.g. ABC Management, acute Hemorrhage Management) take priority over Decontamination
- Externally irradiated patients are not an exposure risk to care givers
- Decontamination may continue as life threatening presentations stabilize
- Create two zones
- Clean Zone
- Patients cross a well demarcated line or roped area AFTER Decontamination
- Dirty Zone (e.g. in Ambulance bay)
- Cover the walls and floor with protective tarp
- Staff working in dirty area should wear full PPE (see above)
- Clean Zone
- Measures
- Remove all clothing (removes 70-90% of contaminants)
- Dispose in bags marked as hazardous waste
- Full body examination
- Examine all skin for shrapnel
- Examine skin for residual radioactive material
- Remove radiaoactive material with forceps and place in lead container
- Consult surgery before removal if material is embedded in vital structures
- Wash skin
- See Skin Decontamination
- Use soap and warm water, mild detergent or 3% Hydrogen Peroxide
- Irrigate eyes, ears, nose and pharynx with Isotonic Saline
- Avoid heavy scrubbing of skin (risk of skin breakdown and contamination)
- Consider chelating agents (e.g. DTPA, Prusssian Blue, Calcium Phosphate, aluminum phosphate)
- Decontamination agents are available for specific exposures (e.g. Uranium: 1.4% bicarbonate solution)
- Expert Consultation (e.g. poison control) is recommended
- Test for residual radiation with Geiger Counter
- Geiger counter may be obtained from emergency personnel (e.g. fire department)
- Evaluate baseline and after Decontamination
- Repeat Decontamination cycle if residual material
- Monitor dirty zone environment for radiation levels
- Continue Decontamination until radiation <2x baseline radiation levels
- Stop after 2 cycles, if radiation does not drop by >=10% between cycles
- Remove all clothing (removes 70-90% of contaminants)
- Staff Safety
- Radiation Exposures are typically insignificant to staff performing Decontamination of residual material
- Staff Radiation Exposure is similar to normal background environmental Radiation Exposure
- Life saving interventions (e.g. ABC Management, acute Hemorrhage Management) take priority over Decontamination
- Triage and Scoring of patients
- European Medical Treatment Protocols for Radiation Accident Victims (METREPOL)
- Clinical and laboratory triage system more appropriate for small incidents
- Radiation Injury Treatment Network (RITN)
- Mass Casualty Incident level scoring (includes computer modeling)
- Other Trauma triage scales
- European Medical Treatment Protocols for Radiation Accident Victims (METREPOL)
- Other evaluation
XI. Management: Other Measures
- Basic Supportive Care
- Intravenous Fluids
- Avoid over-Resuscitation (fluid needs are less than in severe Burn Injury)
- Electrolyte replacement
- Anti-emetics (e.g. Ondansetron)
- Total Parenteral Nutrition may be needed in severe gastrointestinal syndrome
- Analgesics
- NSAIDs
- Acetaminophen
- Opioids for refractory pain
- Maintain gastric acidity (avoid Proton Pump Inhibitors and H2 Blockers)
- May use Sucralfate for Stress Ulcer prevention
- Platelet Transfusion indications
- Platelet Count <20,000 (or <75,000 if perioperative)
- Intravenous Fluids
- Treat specific injuries
- Patient Triage to 4 categories
- Response Categories (RC) are based on triage system used (e.g METREPOL)
- Recovery is expected with minimal supportive care (<1 Gy exposure, RC1)
- No Vomiting in first 3 hours or skin erythema within 24 hours
- Employ basic measures as above
- Outpatient follow-up with complete system review daily for 6 days
- Follow-up at 1 week after exposure
- Moderate Radiation Injury (RC2, 1-2 Gy Exposure)
- Severe Radiation Injury but survival is possible with aggressive supportive care (RC3, >2 Gy Exposure)
- Vomitin within first 2 hours after exposure
- Triage to Intensive Care
- Reevaluate every 6 hours until stable and then every 12 hours for up to 6 days
- Consult hematology, burn specialists
- Reverse Isolation (>2 to 3 Gy exposure)
- Expected to succumb (RC4, >10 Gy exposure, concurrent injuries or inadequate resources)
- Triage to Palliative Care
- Reevaluate every 6 hours for the first 3 days
- Hematopoietic Syndrome with myelosuppression (e.g. Pancytopenia)
- Administer Granulocyte Colony Stimulating Factor (or similar) early
- Perform any emergent surgeries in first 48 hours (cell counts are expected to drop after this)
-
Thyroid Cancer Risk
- Risk of Radioactive Iodine uptake in children and pregnant women
- Give as early as possible (<4 hours is preferred, and ineffective at >12 hours after exposure)
- Give prophylactic Potassium Iodide to patients at risk as early as possible
- Adult: 130 mg orally daily
- Child (over age 3 years old): 65 mg orally daily
- Infant (one month to age 3 years): 32 mg
- Infection Risk
- Perform any urgent or emergent surgery in first 24 to 36 hours
- Treat infections early
- Irradiate blood components prior to transfusion
- Consider prophylactic Antibiotics in Neutropenia
- Evaluate for CMV risk
- Evaluate for Pneumocystitis carinii risk (CD4 <200/ul)
- Cutaneous Radiation Syndrome
- Consult burn specialists
- May apply Linoleic Acid cream
- Consider Betamethasone cream to decrease inflammation
- Consider Pentoxifylline to prevent radiation fibrosis (decreases blood viscosity and increases Blood Flow)
- Internal Radiation Contamination (e.g. Ingestion, Inhalation)
- Consult radiation and hematology specialists
- Consider systemic chelating agents
XII. Resources
- Radiation Emergency Assistance Center/Training Site (REAC/TS, Oak Ridge Institute)
- https://orise.orau.gov/reacts/index.html
- REAC/TS offers emergency Consultation regarding the care of radiation exposed patients
- On call (24/7) assistance from nurse, physician and physicist
- TMT Handbook (Rojas-Palma, 2009)
- https://remm.hhs.gov/tmt-handbook-20091.pdf
- Triage, monitoring and treatment of people exposed to the malevolent use of inonizing radiation
XIII. References
- Vasisht and Falat (2025) Crit Dec Emerg Med 39(11): 4-13
- Acosta and Warrington (2022) Radiation Syndrome, Stat Pearls, Treasure Island, accessed 5/11/2022
- Studer and Swaminathan (2025) EM:Rap, 2/3/2025
- López (2011) Rep Pract Oncol Radiother 16(4):138-46 +PMID: 24376971 [PubMed]